631 related articles for article (PubMed ID: 20300169)
21. Salivary metabolite levels in perinatally HIV-infected youth with periodontal disease.
Schulte F; King OD; Paster BJ; Moscicki AB; Yao TJ; Van Dyke RB; Shiboski C; Ryder M; Seage G; Hardt M;
Metabolomics; 2020 Sep; 16(9):98. PubMed ID: 32915320
[TBL] [Abstract][Full Text] [Related]
22. Effect of masticatory stimulation on the quantity and quality of saliva and the salivary metabolomic profile.
Okuma N; Saita M; Hoshi N; Soga T; Tomita M; Sugimoto M; Kimoto K
PLoS One; 2017; 12(8):e0183109. PubMed ID: 28813487
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of critical factors in the preparation of saliva sample from healthy subjects for metabolomics.
Nam M; Jo SR; Park JH; Kim MS
J Pharm Biomed Anal; 2023 Jan; 223():115145. PubMed ID: 36368133
[TBL] [Abstract][Full Text] [Related]
24. Capillary electrophoresis-mass spectrometry-based metabolome analysis of serum and saliva from neurodegenerative dementia patients.
Tsuruoka M; Hara J; Hirayama A; Sugimoto M; Soga T; Shankle WR; Tomita M
Electrophoresis; 2013 Oct; 34(19):2865-72. PubMed ID: 23857558
[TBL] [Abstract][Full Text] [Related]
25. Metabolome of canine and human saliva: a non-targeted metabolomics study.
Turunen S; Puurunen J; Auriola S; Kullaa AM; Kärkkäinen O; Lohi H; Hanhineva K
Metabolomics; 2020 Aug; 16(9):90. PubMed ID: 32840693
[TBL] [Abstract][Full Text] [Related]
26. Discovery of early-stage biomarkers for diabetic kidney disease using ms-based metabolomics (FinnDiane study).
van der Kloet FM; Tempels FW; Ismail N; van der Heijden R; Kasper PT; Rojas-Cherto M; van Doorn R; Spijksma G; Koek M; van der Greef J; Mäkinen VP; Forsblom C; Holthöfer H; Groop PH; Reijmers TH; Hankemeier T
Metabolomics; 2012 Feb; 8(1):109-119. PubMed ID: 22279428
[TBL] [Abstract][Full Text] [Related]
27. Metabolome-based signature of disease pathology in MS.
Andersen SL; Briggs FBS; Winnike JH; Natanzon Y; Maichle S; Knagge KJ; Newby LK; Gregory SG
Mult Scler Relat Disord; 2019 Jun; 31():12-21. PubMed ID: 30877925
[TBL] [Abstract][Full Text] [Related]
28. Proteomic identification of salivary transferrin as a biomarker for early detection of oral cancer.
Jou YJ; Lin CD; Lai CH; Chen CH; Kao JY; Chen SY; Tsai MH; Huang SH; Lin CW
Anal Chim Acta; 2010 Nov; 681(1-2):41-8. PubMed ID: 21035601
[TBL] [Abstract][Full Text] [Related]
29. Untargeted saliva metabonomics study of breast cancer based on ultra performance liquid chromatography coupled to mass spectrometry with HILIC and RPLC separations.
Zhong L; Cheng F; Lu X; Duan Y; Wang X
Talanta; 2016 Sep; 158():351-360. PubMed ID: 27343615
[TBL] [Abstract][Full Text] [Related]
30. Using an Untargeted Metabolomics Approach to Identify Salivary Metabolites in Women with Breast Cancer.
Xavier Assad D; Acevedo AC; Cançado Porto Mascarenhas E; Costa Normando AG; Pichon V; Chardin H; Neves Silva Guerra E; Combes A
Metabolites; 2020 Dec; 10(12):. PubMed ID: 33322065
[TBL] [Abstract][Full Text] [Related]
31. [Analysis of metabolomics and proteomics based on capillary electrophoresis-mass spectrometry].
Wang F; Wang S; Cong H; Yu B
Se Pu; 2020 Sep; 38(9):1013-1021. PubMed ID: 34213267
[TBL] [Abstract][Full Text] [Related]
32. Elevated Polyamines in Saliva of Pancreatic Cancer.
Asai Y; Itoi T; Sugimoto M; Sofuni A; Tsuchiya T; Tanaka R; Tonozuka R; Honjo M; Mukai S; Fujita M; Yamamoto K; Matsunami Y; Kurosawa T; Nagakawa Y; Kaneko M; Ota S; Kawachi S; Shimazu M; Soga T; Tomita M; Sunamura M
Cancers (Basel); 2018 Feb; 10(2):. PubMed ID: 29401744
[TBL] [Abstract][Full Text] [Related]
33. Salivary metabolomics for cancer detection.
Sugimoto M
Expert Rev Proteomics; 2020 Sep; 17(9):639-648. PubMed ID: 33140667
[No Abstract] [Full Text] [Related]
34. Human Saliva Metabolome for Oral Lichen Planus Biomarker Identification.
Wang X; Liu L; Du Q; Sun Z; Yue E; Xue P; Zhao H
Recent Pat Anticancer Drug Discov; 2021; 16(3):417-425. PubMed ID: 33655848
[TBL] [Abstract][Full Text] [Related]
35. Biochemical analysis of oral fluids for disease detection.
Khurshid Z; Warsi I; Moin SF; Slowey PD; Latif M; Zohaib S; Zafar MS
Adv Clin Chem; 2021; 100():205-253. PubMed ID: 33453866
[TBL] [Abstract][Full Text] [Related]
36. Salivary Metabolomics for Oral Cancer Detection: A Narrative Review.
Panneerselvam K; Ishikawa S; Krishnan R; Sugimoto M
Metabolites; 2022 May; 12(5):. PubMed ID: 35629940
[TBL] [Abstract][Full Text] [Related]
37. Global metabolomic analysis of human saliva and plasma from healthy and diabetic subjects, with and without periodontal disease.
Barnes VM; Kennedy AD; Panagakos F; Devizio W; Trivedi HM; Jönsson T; Guo L; Cervi S; Scannapieco FA
PLoS One; 2014; 9(8):e105181. PubMed ID: 25133529
[TBL] [Abstract][Full Text] [Related]
38. Salivary proteomics for oral cancer biomarker discovery.
Hu S; Arellano M; Boontheung P; Wang J; Zhou H; Jiang J; Elashoff D; Wei R; Loo JA; Wong DT
Clin Cancer Res; 2008 Oct; 14(19):6246-52. PubMed ID: 18829504
[TBL] [Abstract][Full Text] [Related]
39. Salivary metabolites associated with a 5-year tooth loss identified in a population-based setting.
Andörfer L; Holtfreter B; Weiss S; Matthes R; Pitchika V; Schmidt CO; Samietz S; Kastenmüller G; Nauck M; Völker U; Völzke H; Csonka LN; Suhre K; Pietzner M; Kocher T
BMC Med; 2021 Jul; 19(1):161. PubMed ID: 34256740
[TBL] [Abstract][Full Text] [Related]
40. The potentiality of salivary peptide biomarkers for screening patients with periodontal diseases by mass spectrometry.
Tang H; Yuan C; Ma Z; Zhu C; Tong P; Gallagher JE; Sun X; Zheng S
Clin Chim Acta; 2019 Aug; 495():278-286. PubMed ID: 31026423
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
